삼성서울병원

Ko En

방사선종양학과 박원 교수

진료분야
전립선/비뇨기암, 부인암(육종포함), 유방암, 특수방사선치료, 양성자치료
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2008.02 아주대학교 대학원 의학과 졸업(의학박사)
2003.02 연세대학교 대학원 의학과 졸업(의학석사)
1994.02 연세대학교 의과대학 졸업 (의학사)

경력

경력
2015.04 ~현재 삼성서울병원 방사선종양학과 교수
2013.09 ~ 2018.02 삼성서울병원 방사선종양학과 의국장
2009.03 ~ 2015.03 삼성서울병원 방사선종양학과 부교수
2009.09 ~ 2011.08 미국 해외 연수
2005.03 ~ 2009.02 삼성서울병원 방사선종양학과 조교수
2005.03 ~ 2009.02 성균관대학교 의과대학 방사선종양학과 조교수
2004.03 ~ 2005.02 삼성서울병원 방사선종양학과 임상조교수
2003.03 ~ 2004.02 삼성서울병원 방사선종양학과 임상전임강사
2002.05 ~ 2003.01 삼성서울병원 방사선종양학과 전임의
1999.02 방사선종양학과 전문의 자격 취득
1995.02 ~ 1999.02 신촌세브란스병원 방사선종양학과 레지던트 과정 수료
1994.03 ~ 1995.02 영동세브란스병원 인턴과정 수료

학회활동

학회활동
대한방사선종양학회 정회원
대한암학회 정회원
한국유방암학회 정회원
2021.11 ~ 현재 대한방사선종양학회 고시이사
2015.10 ~ 2021.12 대한방사선종양학회 편집이사

수상이력

수상이력
2015.10 대한방사선종양학회 최우수 학술상
  • J MED IMAG RADIAT ON 2024 10.1111/1754-9485.13639 Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer Lee, TH; Pyo, H; Yoo, GS; Jeon, SS; Seo, SI; Jeong, BC; Jeon, HG; Sung, HH; Kang, MY; Song, W; Chung, JH; Bae, BK; Park, W
    View PubMed
  • MED PHYS 2024 10.1002/mp.16976 CycleSeg: Simultaneous synthetic CT generation and unsupervised segmentation for MR-only radiotherapy treatment planning of prostate cancer Luu, HM; Yoo, GS; Park, W; Park, SH
    View PubMed
  • BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01547-9 Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H
    View PubMed
  • J KOREAN PHYS SOC 2024 10.1007/s40042-023-00998-1 Search for practical scaling factors of Bragg peak arrangement for line-scanning proton beam therapy in RayStation Chung, K; Kim, N; Cho, WK; Kim, H; Oh, D; Park, W; Park, HC; Lim, D
    View PubMed
  • GYNECOL ONCOL 2024 10.1016/j.ygyno.2024.01.019 Diagnostic assessments and treatment results of well-differentiated gastric-type adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter retrospective analysis of KROG 22-03 study Choi, KH; Lee, HC; Kim, YS; Park, W; Kim, YB; Jung, W; Kim, KS; Eom, KY; Kim, JH; Lee, JH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-43202-x Long-term findings of rectal endoscopy and rectal bleeding after moderately hypofractionated, intensity-modulated radiotherapy for prostate cancer Bae, BK; Kim, JE; Pyo, H; Hong, SN; Park, W
    View PubMed
  • BREAST 2023 10.1016/j.breast.2023.103594 Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H
    View PubMed
  • CANCERS 2023 10.3390/cancers15225473 The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM
    View PubMed
  • RADIAT ONCOL 2023 10.1186/s13014-023-02357-7 Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach Kim, N; Kim, H; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Park, YH; Kim, JY
    View PubMed
  • CANCERS 2023 10.3390/cancers15194720 Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer Shin, J; Kim, JY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, W; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • BREAST CANCER RES TR 2023 10.1007/s10549-023-07146-0 Quantitative assessment of breast volume changes after whole-breast irradiation for breast cancer using breast auto-segmentation Lee, TH; Ahn, SH; Chung, K; Park, W; Cho, WK; Kim, N; Kim, TG; Kim, H
    View PubMed
  • BREAST CANCER RES TR 2023 10.1007/s10549-023-07150-4 Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons Park, S; Choi, C; Kim, H; Shin, YJ; Oh, Y; Park, W; Cho, WK; Kim, N
    View PubMed
  • PROSTATE INT 2023 10.1016/j.prnil.2023.07.002 Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer Lee, TH; Pyo, H; Yoo, GS; Lee, HM; Jeon, SS; Il Seo, S; Jeong, BC; Jeon, HG; Sung, HH; Kang, M; Song, W; Chung, JH; Bae, BK; Park, W
    View PubMed
  • INT J RADIAT ONCOL 2023 10.1016/j.ijrobp.2023.03.048 The Updated World Health Organization Classification Better Predicts Survivalin Patients With Endocervical Adenocarcinoma (KROG20-07) Cho, WK; Kim, HS; Park, W; Kim, YS; Kang, J; Kim, YB; Kim, YS; Kim, YJ; Kim, KR; Kim, JH; Kwon, SY; Choi, JH; Yoon, M; Kim, NI
    View PubMed
  • J KOREAN PHYS SOC 2023 10.1007/s40042-023-00897-5 Searching for optimized selection of Monte Carlo dose calculation parameters for scanned beam proton therapy in RayStation Kim, H; Chung, KZ; Han, YY; Park, W; Park, HC; Lim, D; Choi, DH
    View PubMed
  • JPN J CLIN ONCOL 2023 10.1093/jjco/hyad106 Recent trends in radiotherapy use for major cancers in Korea Yang, K; Lee, JE; Park, W; Ahn, YC; Huh, SJ
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.389 Recent Trends of Medical Expenses Associated with Radiation Therapy in Korea Based on HIRA Big Data Lee, JE; Yang, K; Ahn, YC; Park, W; Huh, SJ
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.343 Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder Kim, H; Jeong, BC; Hong, J; Kwon, GY; Kim, CK; Park, W; Pyo, H; Song, W; Sung, HH; Hong, JY; Park, SH
    View PubMed
  • BMJ OPEN 2023 10.1136/bmjopen-2022-069691 Low-dose RaDiation therapy for patients with KNee osteoArthritis (LoRD-KNeA): a protocol for a sham-controlled randomised trial Kim, BH; Shin, K; Kim, MJ; Kim, HJ; Ro, D; Wang, JH; Lee, DH; Kim, DH; Sun, JY; Lee, JH; Kim, JY; Hong, EH; Cho, SJ; Han, HS; Park, W
    View PubMed
  • EJSO-EUR J SURG ONC 2023 10.1016/j.ejso.2022.11.099 Omission of axillary lymph node dissection in patients with ypN plus breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06) Park, Y; Shin, YS; Kim, K; Shin, KH; Chang, JH; Kim, SS; Jung, JH; Park, W; Kim, H; Kim, YB; Ahn, SJ; Kim, M; Kim, JH; Cha, HJ; Kim, TG; Park, HJ; Lee, SY
    View PubMed
  • BREAST 2022 10.1016/j.breast.2022.09.004 Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ
    View PubMed
  • INT J GYNECOL CANCER 2022 10.1136/ijgc-2022-003971 Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification Bae, BK; Cho, WK; Kim, BG; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Park, W
    View PubMed
  • BMC CANCER 2022 10.1186/s12885-022-10285-0 Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy Lee, TH; Chang, JH; Jang, BS; Kim, JS; Kim, TH; Park, W; Kim, YB; Kim, SS; Han, W; Lee, HB; Shin, KH
    View PubMed
  • RADIAT ONCOL 2022 10.1186/s13014-022-02140-0 Dummy run quality assurance study in the Korean Radiation Oncology Group 19-09 multi-institutional prospective cohort study of breast cancer Kim, M; Park, B; Kim, H; Kim, YJ; Choi, DJ; Chung, W; Kim, YJ; Shin, HS; Im, JH; Suh, CO; Kim, JH; Ha, B; Kim, MY; Park, J; Lee, J; Ahn, SJ; Lee, SY; Kusumawidjaja, G; Lim, F; Cho, WK; Kim, H; Choi, DH; Park, W
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e71 Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy Cho, WK; Kim, HS; Park, W; Chang, CS; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG
    View PubMed
  • JPN J CLIN ONCOL 2022 10.1093/jjco/hyac161 Patterns of regional recurrence according to molecular subtype in patients with pN2 breast cancer treated with limited field regional irradiation Cho, WK; Park, W; Jeong, Y; Kim, H; Kim, N
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.985 Optimal Definition of Biochemical Recurrence in Patients Who Receive Salvage Radiotherapy Following Radical Prostatectomy for Prostate Cancer Lee, SU; Kim, JS; Kim, YS; Cho, J; Choi, SH; Nam, TK; Jeong, SM; Kim, Y; Choi, Y; Lee, DE; Park, W; Cho, KH
    View PubMed
  • INT J GYNECOL CANCER 2022 10.1136/ijgc-2022-003834 Role of salvage radiotherapy for recurrent ovarian cancer Bae, BK; Cho, WK; Lee, JW; Kim, TJ; Choi, CH; Lee, YY; Park, W
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e32 Oncologic outcomes according to the level of disease burden in patients with metachronous distant metastases from uterine cervical cancer: a Korean Radiation Oncology Group study (KROG 18-10) Park, S; Park, W; Park, SH; Kim, JY; Kim, JH; Kim, H; Kim, YS; Cho, WK; Yoon, WS; Yang, DS
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt2021.933 Postmastectomy Radiation Therapy for Node-Negative Breast Cancer of 5 cm or Larger Tumors: A Multicenter Retrospective Analysis (KROG 20-03) Kim, K; Jung, J; Kim, H; Jung, W; Shin, KH; Chang, JH; Kim, SS; Park, W; Chang, JS; Kim, YB; Ahn, SJ; Lee, IJ; Lee, JH; Park, HJ; Cha, J; Kim, J; Choi, JH; Koo, T; Kwon, J; Kim, JH; Kim, MY; Park, SH; Kim, YJ
    View PubMed
  • ASIA-PAC J CLIN ONCO 2022 10.1111/ajco.13758 Clinical outcomes after positron emission tomography/computed tomography-based image-guided brachytherapy for cervical cancer Kim, N; Park, W; Cho, WK; Cho, YS
    View PubMed
  • INVESTIG CLIN UROL 2022 10.4111/icu.20210407 Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder Sung, HH; Kim, H; Kim, R; Kim, CK; Kwon, GY; Park, W; Song, W; Jeong, BC; Park, SH
    View PubMed
  • TAIWAN J OBSTET GYNE 2022 10.1016/j.tjog.2022.02.023 Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy? Cho, WK; Park, W; Kim, H; Kim, YJ; Kim, YS
    View PubMed
  • CLIN BREAST CANCER 2022 10.1016/j.clbc.2021.06.013 Quantitative Changes in Skin Composition Parameters after Radiation Therapy According to Surgery Types Among Patients with Breast Cancer: A Prospective Study Yoo, GS; Kang, D; Kim, IR; Park, H; Kim, E; Cho, WK; Kim, H; Choi, DH; Ma, JC; Park, W
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.023 Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival Noh, KW; Kim, B; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Cho, WK; Park, W; Lee, YY
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06483-2 Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching Kim, N; Kim, H; Park, W; Choi, DH; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Yu, J; Lee, SK; Jeon, BJ; Pyon, JK; Mun, GH; Kim, TG
    View PubMed
  • CANCERS 2022 10.3390/cancers14010040 Feasibility of Synthetic Computed Tomography Images Generated from Magnetic Resonance Imaging Scans Using Various Deep Learning Methods in the Planning of Radiation Therapy for Prostate Cancer Yoo, GS; Luu, HM; Kim, H; Park, W; Pyo, H; Han, Y; Park, JY; Park, SH
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2020.1373 Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma Yoo, GS; Park, W; Pyo, H; Jeong, BC; Jeon, HG; Kang, M; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Park, BK; Kim, CK; Park, SY; Kwon, GY
    View PubMed
  • ANTIOXIDANTS-BASEL 2021 10.3390/antiox10111769 MnTnHex-2-PyP5+, Coupled to Radiation, Suppresses Metastasis of 4T1 and MDA-MB-231 Breast Cancer via AKT/Snail/EMT Pathways Shin, SW; Choi, C; Kim, H; Kim, Y; Park, S; Kim, SY; Batinic-Haberle, I; Park, W
    View PubMed
  • JAMA ONCOL 2021 10.1001/jamaoncol.2021.6036 Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer A Randomized Phase 3 Clinical Trial Kim, YB; Byun, HK; Kim, DY; Ahn, SJ; Lee, HS; Park, W; Kim, SS; Kim, JH; Lee, KC; Lee, IJ; Kim, WT; Shin, HS; Kim, K; Shin, KH; Nam, CM; Suh, CO
    View PubMed
  • INT J RADIAT ONCOL 2021 10.1016/j.ijrobp.2021.07.005 What Is High-risk Breast Cancer With Pathologically Negative Lymph Nodes for Regional Recurrence? Kim, SW; Cho, WK; Choi, DH; Kim, H; Cho, O; Park, W; Chun, M
    View PubMed
  • TRIALS 2021 10.1186/s13063-021-05708-5 Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial Park, G; Kim, YJ; Ahn, H; Park, W; Lee, JS; Kim, YS
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e72 Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features Kim, N; Park, W; Cho, WK; Bae, DS; Kim, BG; Lee, JW; Choi, CH; Kim, TJ; Lee, YY
    View PubMed
  • MED PHYS 2021 10.1002/mp.15182 Improvement of megavoltage computed tomography image quality for adaptive helical tomotherapy using cycleGAN-based image synthesis with small datasets Lee, D; Jeong, SW; Kim, SJ; Cho, H; Park, W; Han, Y
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2020.1251 Early Metabolic Response Assessed Using F-18-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer Kim, N; Park, W; Cho, WK; Bae, DS; Kim, BG; Lee, JW; Kim, TJ; Choi, CH; Lee, YY; Cho, YS
    View PubMed
  • CANCERS 2021 10.3390/cancers13112732 Optimizing External Beam Radiotherapy as per the Risk Group of Localized Prostate Cancer: A Nationwide Multi-Institutional Study (KROG 18-15) Choi1, SH; Kim, YS; Yu, J; Nam, TK; Kim, JS; Jang, BS; Kim, JH; Kim, Y; Jeong, BK; Chang, AR; Park, YH; Lee, SU; Cho, KH; Kim, JH; Kim, H; Choi, Y; Kim, YJ; Lee, DS; Shin, YJ; Shim, SJ; Park, W; Cho, J
    View PubMed
  • CANCERS 2021 10.3390/cancers13112692 Comparing the Effectiveness of a Wearable Activity Tracker in Addition to Counseling and Counseling Only to Reinforce Leisure-Time Physical Activity among Breast Cancer Patients: A Randomized Controlled Trial Kong1, S; Lee, JK; Kang, D; Kim, N; Shim, YM; Park, W; Choi, D; Cho, J
    View PubMed
  • BREAST CANCER RES TREAT 2021 10.1007/s10549-021-06296-3 Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study Kim1, H; Kim, YJ; Park, D; Park, WY; Choi, DH; Park, W; Cho, WK; Kim, N
    View PubMed
  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • RADIOTHER ONCOL 2021 10.1016/j.radonc.2021.02.033 Longitudinal impact of postmastectomy radiotherapy on arm lymphedema in patients with breast cancer: An analysis of serial changes in arm volume measured by infrared optoelectronic volumetry Kim1, N; Kim, H; Hwang, JH; Park, W; Cho, WK; Yeo, SM; Lee, H; Lee, SK
    View PubMed
  • SKIN PHARMACOL PHYS 2021 10.1159/000515962 Chronological Skin Changes Through Postmastectomy Radiotherapy Based on Radiotherapy Techniques: Using Quantitative Dermatological Measurements Yang1, K; Park, W; Cho, J; Kang, D; Choi, DH; Kim, H; Cho, WK; Park, H; Kim, E
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e43 Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06) Kim1, N; Park, W
    View PubMed
  • BREAST 2021 10.1016/j.breast.2021.01.003 Impact of radiation dose on complications among women with breast cancer who underwent breast reconstruction and post-mastectomy radiotherapy: A multi-institutional validation study Chung1, SY; Chang, JS; Shin, KH; Kim, JH; Park, W; Kim, H; Kim, K; Lee, IJ; Yoon, WS; Cha, J; Lee, KC; Kim, JH; Choi, JH; Ahn, SJ; Ha, B; Lee, SY; Lee, DS; Lee, J; Shin, SO; Lee, SW; Choi, J; Kim, MY; Kim, YJ; Im, JH; Suh, CO; Kim, YB
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e23 Impact of Breast Reconstruction on Biophysical Parameters of Mammary Skin in Patients Receiving Postmastectomy Radiotherapy for Breast Cancer Kim1, H; Kang, D; Park, W; Cho, J; Park, H; Kim, E; Choi, DH; Cho, WK; Jeon, BJ; Lee, KT
    View PubMed
  • EUR J OBSTET GYN R B 2021 10.1016/j.ejogrb.2021.01.034 Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03) Cho1, WK; Park, W; Kim, YS; Kang, HC; Kim, JH; Kim, KS; Choi, KH; Chang, SK; Ahn, KJ; Lee, SH; Kim, S; Kim, J; Eom, KY; Lee, J; Lee, JH; Choi, JH
    View PubMed
  • BREAST 2021 10.1016/j.breast.2020.12.011 Outcome of radiotherapy for clinically overt metastasis to the internal mammary lymph node in patients receiving neoadjuvant chemotherapy and breast cancer surgery Kim1, H; Kim, SS; Lee, IJ; Shin, KH; Kim, K; Jung, JB; Kim, Y; Chang, JS; Choi, DH; Park, W; Yang, K; Chang, JH; Cha, J; Kim, JH; Lee, DS
    View PubMed
  • J RADIAT RES 2021 10.1093/jrr/rraa085 A dummy-run evaluation of post-operative hypofractionated intensity-modulated radiation therapy (POHIM-RT) trials for cervical cancer Cho1, WK; Kim, H; Park, W; Kim, SW; Kim, J; Lee, KK; Oh, JG; Yoon, MS; Song, JY; Ahn, KJ; Park, SK; Choi, JH; Bak, J
    View PubMed
  • INT J RADIAT RES 2021 10.18869/acadpub.ijrr.19.1.231 Usability assessment of cone beam computed tomography with a full-fan mode bowtie filter compared to that with a half-fan mode bowtie filter Choi1, WK; Park, W; Kim, S
    View PubMed
  • J BREAST CANC 2020 10.4048/jbc.2020.23.e66 Survival and Prognostic Factors for Breast Cancer Patients with Regional Oligo-Recurrence Baek1, JY; Choi, DH; Park, W; Kim, H; Cho, WK; Yoo, GS
    View PubMed
  • CANCERS 2020 10.3390/cancers12113261 Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) Kim1, H; Kim, H; Park, W; Baek, JY; Ahn, SJ; Kim, MY; Park, SH; Lee, IJ; Ha, I; Kim, JH; Kim, TH; Lee, KC; Lee, HS; Kim, TG; Kim, JH; Lee, JH; Jung, J; Cho, O; Chang, JS; Kim, ES; Jo, IY; Koo, T; Kim, K; Park, HJ; Shin, YJ; Ha, B; Kwon, J; Lee, JH; Moon, S
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9113471 Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer Analysis by Radiation Phase and Histologic Type Kang1, JH; Cho, WK; Yeo, HJ; Jeong, SY; Noh, JJ; Shim, JI; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Park, W; Choi, CH
    View PubMed
  • ASIA-PAC J CLIN ONCO 2020 10.1111/ajco.13444 Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer Kim1, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY
    View PubMed
  • MEDICINA-LITHUANIA 2020 10.3390/medicina56100514 Germline BRCA Mutation and Clinical Outcomes in Breast Cancer Patients Focusing on Survival and Failure Patterns A Long-Term Follow-Up Study of Koreans Kim1, H; Choi, DH; Park, W
    View PubMed
  • JPN J CLIN ONCOL 2020 10.1093/jjco/hyaa091 Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer Cho1, WK; Kim, YJ; Kim, H; Kim, YS; Park, W
    View PubMed
  • SUPPORT CARE CANCER 2020 10.1007/s00520-020-05751-z Detection of early changes in the muscle properties of the pectoralis major in breast cancer patients treated with radiotherapy using a handheld myotonometer Kim1, Y; An, SY; Park, W; Hwang, JH
    View PubMed
  • GYNECOL ONCOL 2020 10.1016/j.ygyno.2020.02.017 Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer Choi1, CH; Chung, JY; Kang, JH; Paik, ES; Lee, YY; Park, W; Byeon, SJ; Chung, EJ; Kim, BG; Hewitt, SM; Bae, DS
    View PubMed
  • J GYNECOL ONCOL 2020 10.3802/jgo.2020.31.e35 Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor Kim1, H; Park, W; Kim, YS; Kim, YJ
    View PubMed
  • GYNECOL ONCOL 2020 10.1016/j.ygyno.2020.02.031 Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy Kim1, H; Cho, WK; Kim, YJ; Kim, YS; Park, W
    View PubMed
  • INT J MOL SCI 2020 10.3390/ijms21082691 Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation Choi1, C; Cho, WK; Park, S; Shin, SW; Park, W; Kim, H; Choi, DH
    View PubMed
  • J BREAST CANC 2020 10.4048/jbc.2020.23.e14 Cervical Lymph Node Involvement above the Supraclavicular Fossa in Breast Cancer: Comparison with Stage IIIC (KROG 18-02) Kim1, JS; Kim, K; Shin, KH; Kim, JH; Ahn, SD; Kim, SS; Kim, YB; Chang, JS; Choi, DH; Park, W; Kim, TH; Chun, M; Cha, J; Kim, JH; Lee, DS; Lee, SY; Park, HJ
    View PubMed
  • RADIAT ONCOL 2020 10.1186/s13014-020-1464-0 Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer Yang1, K; Kim, H; Choi, DH; Park, W; Noh, JM; Cho, WK
    View PubMed
  • CLIN BREAST CANCER 2020 10.1016/j.clbc.2019.09.004 Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14) Kim1, K; Kim, SS; Shin, KH; Kim, JH; Ahn, SD; Choi, DH; Park, W; Lee, SY; Chun, M; Kim, JH; Kim, YB; Cha, J; Park, HJ; Lee, DS; Jung, W
    View PubMed
  • BREAST 2020 10.1016/j.breast.2019.10.017 Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI Kim1, H; Park, W; Kim, SS; Ahn, SJ; Kim, YB; Kim, TH; Kim, JH; Choi, JH; Park, HJ; Chang, JS; Choi, DH
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.126 Clinical Outcomes of Postoperative Radiotherapy Following Radical Prostatectomy in Patients with Localized Prostate Cancer: A Multicenter Retrospective Study (KROG 18-01) of a Korean Population Lee1, SU; Cho, KH; Park, W; Cho, WK; Kim, JS; Wee, CW; Kim, YS; Kim, JH; Nam, TK; Cho, J; Jeong, SM; Kim, Y; Shim, SJ; Choi, Y; Kim, JS
    View PubMed
  • EUR RADIOL 2019 10.1007/s00330-019-06204-w Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy Gu1, KW; Kim, CK; Choi, CH; Yoon, YC; Park, W
    View PubMed
  • EUR RADIOL 2019 10.1007/s00330-019-06198-5 Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy Lee1, J; Kim, CK; Gu, KW; Park, W
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-51959-3 Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer Lee1, YY; Cho, YJ; Shin, SW; Choi, C; Ryu, JY; Jeon, HK; Choi, JJ; Hwang, JR; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Park, W; Lee, JW
    View PubMed
  • TUMORI 2019 10.1177/0300891618792476 Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy Kim1, TG; Park, W; Kim, H; Choi, DH; Park, HC; Kim, SH; Cho, YB; Yun, SH; Kim, HC; Lee, WY; Lee, J; Kang, KM
    View PubMed
  • CLIN BREAST CANCER 2019 10.1016/j.clbc.2019.04.003 The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08) Choi1, N; Kim, K; Shin, KH; Kim, Y; Moon, HG; Park, W; Choi, DH; Kim, SS; Do Ahn, S; Kim, TH; Chun, M; Kim, YB; Kim, S; Choi, BO; Kim, JH
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.423 Korean First Prospective Phase II Study, Feasibility of Prone Position in Postoperative Whole Breast Radiotherapy: A Dosimetric Comparison Chung1, Y; Yu, JI; Park, W; Choi, DH
    View PubMed
  • BREAST 2019 10.1016/j.breast.2019.06.005 Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer? Cho1, WK; Choi, DH; Park, W; Kim, H; Cha, H
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.575 Impact of Regions Nodal Irradiation or Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14) Kim1, K; Jeong, Y; Shin, KH; Kim, JH; Ahn, SD; Kim, SS; Suh, CO; Kim, YB; Choi, DH; Park, W; Cha, J; Chun, M; Lee, DS; Lee, SY; Kim, JH; Park, HJ; Jung, W
    View PubMed
  • INT J GYNECOL CANCER 2019 10.1136/ijgc-2019-000615 Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer Cho1, WK; Kim, YI; Park, W; Yang, K; Kim, H; Cha, H
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e42 Gastric Complications after Adjuvant Radiotherapy for Breast Cancer Cho1, WK; Choi, DH; Park, W; Kim, H; Kim, S; Shin, MH; Cha, H
    View PubMed
  • BREAST J 2019 10.1111/tbj.13304 Heart-sparing radiotherapy with three-dimensional printing technology after mastectomy for patients with left breast cancer Yang1, K; Park, W; Ju, SG; Chung, Y; Choi, DH; Cha, H; Park, JY; Shin, JS; Na, CH
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.424 Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418) Yoo1, GS; Park, W; Yu, JI; Choi, DH; Kim, YJ; Shin, KH; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, J
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e25 The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes Cho1, WK; Park, W; Choi, DH; Kim, YB; Kim, JH; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ
    View PubMed
  • BREAST 2019 10.1016/j.breast.2019.02.010 Is tumor bed boost necessary in patients who achieved ypCR following neoadjuvant chemotherapy and breast conserving therapy? (KROG 12-05 and 16-16) Cho1, WK; Park, W; Choi, DH; Kim, YB; Su, CO; Shin, KH; Chie, EK; Kim, JH; Ahn, SD; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ; Shin, HS; Lee, HS; Lee, NK
    View PubMed
  • CANCERS 2019 10.3390/cancers11050680 Clinical Significance of Lymph-Node Ratio in Determining Supraclavicular Lymph-Node Radiation Therapy in pN1 Breast Cancer Patients Who Received Breast-Conserving Treatment (KROG 14-18): A Multicenter Study Kim1, J; Park, W; Kim, JH; Choi, DH; Kim, YJ; Lee, ES; Shin, KH; Kim, JH; Kim, K; Kim, YB; Ahn, SJ; Lee, JH; Chun, M; Lee, HS; Kim, JS; Cha, J
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e1 Central Nervous System Failure in Korean Breast Cancer Patients with HER2-Enriched Subtype: Korean Radiation Oncology Group 16-15 Multicenter Retrospective Study Kim1, K; Shin, KH; Kim, JH; Choi, DH; Park, W; Kim, YB; Kim, HJ; Kim, JH; Park, H; Lee, SY; Kim, J; Oh, DH; Kim, IA
    View PubMed
  • BREAST 2019 10.1016/j.breast.2018.11.004 Adjuvant radiation therapy in small ductal carcinoma in situ Cho1, WK; Choi, DH; Kim, H; Noh, JM; Park, W; Cha, H
    View PubMed
  • CLIN BREAST CANCER 2019 10.1016/j.clbc.2018.08.009 Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16) Cho1, WK; Park, W; Choi, DH; Kim, YB; kim, JH; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0209998 A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16) Byun1, SJ; Park, W; Cho, KH; Cho, J; Chang, AR; Kang, KM; Kim, JH; Kim, JH
    View PubMed
  • HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3 The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.575 Breast Conservation Therapy versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23 Kim1, K; Park, HJ; Shin, KH; Kim, JH; Choi, DH; Park, W; Ahn, SD; Kim, SS; Kim, DY; Kim, TH; Kim, JH; Kim, J
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010 Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment Cho1, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4838-3 Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08) Choi1, N; Kim, K; Shin, KH; Kim, Y; Moon, HG; Park, W; Choi, DH; Kim, SS; Do Ahn, S; Kim, TH; Chun, M; Kim, YB; Kim, S; Choi, BO; Kim, JH
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e37 Patterns of Practice in Radiotherapy for Breast Cancer in Korea Park1, HJ; Oh, DH; Shin, KH; Kim, JH; Choi, DH; Park, W; Suh, CO; Kim, YB; Ahn, SD; Kim, SS
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.346 The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04) Kwon1, J; Eom, KY; Kim, YS; Park, W; Chun, M; Lee, J; Kim, YB; Yoon, WS; Kim, JH; Choi, JH; Chang, SK; Jeong, BK; Lee, SH; Cha, J
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.206 Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy? Cho1, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4707-0 Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapy Chang1, JH; Shin, KH; Ahn, SD; Park, HJ; Chie, EK; Kim, JH; Kim, SS; Kim, YB; Park, W; Kim, YJ; Shin, HS; Kim, JH; Lee, SY; Kim, K; Park, KR; Jeong, BK; Kim, JY; Kim, S
    View PubMed
  • BREAST 2018 10.1016/j.breast.2018.01.004 Comparison of failure patterns between tubular breast carcinoma and invasive ductal carcinoma (KROG 14-25) Cho1, WK; Choi, DH; Lee, J; Park, W; Kim, YB; Suh, CO; Shin, KH; Jeon, SH; Kim, K; Park, KR; Kim, JH; Ahn, SJ; Yoon, WS; Yang, DS; Kim, J; Lee, JH; Yea, JW
    View PubMed
  • TUMORI 2018 10.5301/tj.5000697 Risk prediction model for disease-free survival in women with early-stage cervical cancers following postoperative (chemo)radiotherapy Je1, HU; Han, S; Kim, YS; Nam, JH; Park, W; Song, S; Song, C; Kim, JH; Kim, J; Yoon, WS; Yoon, MS; Choi, JH; Kim, JY
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.1.91 Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy Park1, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH
    View PubMed
  • INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001155 Tumor Boost Using External Beam Radiation in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy Outcome From a Multicenter Retrospective Study (Korean Radiation Oncology Group 1419) Kim1, H; Kim, YS; Joo, JH; Eom, KY; Park, W; Kim, JH; Lee, JH; Kim, YS; Lee, SH; Ahn, K; Kim, YB; Lee, MY; Chang, SK
    View PubMed
  • RADIOTHER ONCOL 2018 10.1016/j.radonc.2017.09.031 Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume Chang1, JS; Lee, J; Chun, M; Shin, KH; Park, W; Lee, JH; Kim, JH; Yoon, WS; Lee, LJ; Kim, J; Park, HL; Kim, YB
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.20.4.327 Selective Radiation Therapy for Ductal Carcinoma In Situ Following Breast-Conserving Surgery According to Age and Margin Width: Korean Radiation Oncology Group 11-04 and 16-02 Studies Kim1, K; Kim, JH; Kim, YB; Suh, CO; Shin, KH; Kim, JH; Kim, TH; Jung, SY; Choi, DH; Park, W; Ahn, SD; Kim, SS; Yea, JW; Kang, MK; Kim, DW; Kim, YJ
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22511 Elevated CEA is associated with worse survival in recurrent rectal cancer Cho1, WK; Choi, DH; Park, HC; Park, W; Yu, JI; Park, YS; Park, JO; Lim, HY; Kang, WK; Kim, HC; Cho, YB; Yun, SH; Lee, WY
    View PubMed
  • JPN J CLIN ONCOL 2017 10.1093/jjco/hyx120 Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy Park1, JS; Lim, DH; Ahn, YC; Park, W; Kim, SJ; Kim, WS; Kim, K
    View PubMed
  • ANTIOXID REDOX SIGN 2017 10.1089/ars.2016.6889 Mechanism of the Antitumor and Radiosensitizing Effects of a Manganese Porphyrin, MnHex-2-PyP Shin1, SW; Choi, C; Lee, GH; Son, A; Kim, SH; Park, HC; Batinic-Haberle, I; Park, W
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.508 Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418) Kim1, YJ; Park, W; Ha, B; Park, B; Joo, J; Kim, TH; Park, IH; Lee, KS; Lee, ES; Shin, KH; Kim, H; Il Yu, J; Choi, DH; Huh, SJ; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, JY
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.382 Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study Kim1, H; Park, W; Yu, JI; Choi, DH; Huh, SJ; Kim, YJ; Lee, ES; Lee, KS; Kang, HS; Park, IH; Shin, KH; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, J
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.20.3.228 Meeting Highlights:The Second Consensus Conference for Breast Cancer Treatment in Korea Lee1, S; Park, IH; Park, S; Sohn, J; Jeong, J; Ahn, SG; Lee, IJ; Lee, HK; Lee, SA; Park, W; Lee, KH; Kim, SW; Hae, SA; Jung, KH; Son, BH
    View PubMed
  • INT J GYNECOL CANCER 2017 10.1097/IGC.0000000000001030 Oncologic Outcomes After Adjuvant Radiotherapy for Stage II Endometrial Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-10) Jung1, J; Kim, YS; Joo, JH; Park, W; Lee, JH; Kim, JH; Yoon, WS; Lee, SH; Eom, KY; Kim, YB
    View PubMed
  • ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652 Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy Kim1, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.16241 Possible benefits from post-mastectomy radiotherapy in nodenegative breast cancer patients: a multicenter analysis in Korea (KROG 14-22) Park1, HJ; Shin, KH; Kim, JH; Ahn, SD; Kim, SS; Kim, YB; Park, W; Kim, YJ; Shin, HS; Kim, JH; Lee, SY; Kim, K; Park, KR; Jeong, BK
    View PubMed
  • QUAL LIFE RES 2017 10.1007/s11136-017-1526-4 Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study Lee1, J; Park, W; Choi, DH; Huh, SJ; Kim, IR; Kang, D; Cho, J
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.405 Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23) Park1, HJ; Shin, KH; Kim, JH; Ahn, SD; Kim, JY; Park, W; Kim, YB; Kim, YJ; Kim, JH; Kim, K; Park, KR; Shin, HS; Jeong, BK; Lee, SY; Kim, S
    View PubMed
  • Int J Gynecol Cancer. 2017 Mar;27(3):507-513. doi: 10.1097/IGC.0000000000000909. Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients Yang K11, Park W, Huh SJ, Park BK, Kim CK, Kim BG, Bae DS, Lee JW.
    View PubMed
  • PLoS One. 2017 Mar 16;12(3):e0173476. doi: 10.1371/journal.pone.0173476. eCollection 2017. Variability in target delineation of cervical carcinoma: A Korean radiation oncology group study (KROG 15-06) Joo JH11, Kim YS1, Cho BC1, Jeong CY1, Park W2, Kim HJ3, Yoon WS4, Yoon MS5, Kim JY6, Choi JH7, Choi Y8, Kim JY9.
    View PubMed
  • Breast Cancer Res Treat. 2017 Feb;162(1):77-83. doi: 10.1007/s10549-017-4111-1. Epub 2017 Jan 12. Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02) Kim K11, Jung SY2, Shin KH3, Kim JH4, Han W5, Lee HB5, Huh SJ6, Choi DH6, Park W6, Ahn SD7, Kim SS7, Kim JH8, Suh CO9, Kim YB9, Kim IA4,10, Kim S4,11, Kim YJ1.
    View PubMed
  • Oncotarget. 2017 Jan 3;8(1):1796-1804. doi: 10.18632/oncotarget.12882. Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418) Kim H11, Park W2, Yu JI2, Choi DH2, Huh SJ2, Kim YJ3, Lee ES3, Lee KS3, Kang HS3, Park IH3, Shin KH4, Kim K5, Park KR5, Kim YB6, Ahn SJ7, Lee JH8, Kim JH9, Chun M10, Lee HS11, Kim JS12, Lee JY13.
    View PubMed
  • Breast Cancer Res Treat. 2017 Jan;161(1):95-102. doi: 10.1007/s10549-016-4034-2. Epub 2016 Oct 25. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer Kim H11, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.
    View PubMed
  • J Gynecol Oncol. 2016 Nov;27(6):e58. doi: 10.3802/jgo.2016.27.e58. Epub 2016 Jul 11. Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08) Cha J11, Kim YS2, Park W3, Kim HJ4, Kim JY5, Kim JH6, Kim J7, Yoon WS8, Kim JW9, Kim YB10.
    View PubMed
  • Eur J Surg Oncol. 2016 Oct;42(10):1497-505. doi: 10.1016/j.ejso.2016.07.003. Epub 2016 Jul 14. Impact of paraaortic lymphadenectomy for endometrial cancer with positive pelvic lymph nodes: A Korean Radiation Oncology Group study (KROG 13-17) Yoon MS11, Park W2, Huh SJ3, Kim HJ4, Kim YS5, Kim YB6, Kim JY7, Lee JH8, Kim HJ9, Cha J10, Kim JH11, Kim J12, Yoon WS13, Choi JH14, Chun M15, Choi Y16, Chang SK17, Lee KK18, Kim M19, Jeong JU1, Nam TK20.
    View PubMed
  • Oncotarget. 2016 Sep 20;7(38):62676-62686. doi: 10.18632/oncotarget.10445. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy Yu JI11, Lee H2, Park HC1, Choi DH1, Choi YL3, Do IG4, Kim HC5, Lee WY5, Yun SH5, Cho YB5, Huh JW5, Park YA6, Park YS6, Park JO6, Kim ST6, Park W1.
    View PubMed
  • J Breast Cancer. 2016 Sep;19(3):275-282. Epub 2016 Sep 23. Radiation Pneumonitis in Association with Internal Mammary Node Irradiation in Breast Cancer Patients: An Ancillary Result from the KROG 08-06 Study Choi J11, Kim YB1, Shin KH2, Ahn SJ3, Lee HS4, Park W5, Kim SS6, Kim JH7, Lee KC8, Kim DW9, Suh HS10, Park KR10, Shin HS11, Suh CO1.
    View PubMed
  • J Gynecol Oncol. 2016 Jul;27(4):e33. doi: 10.3802/jgo.2016.27.e33. Epub 2016 Feb 3. Current status of brachytherapy in Korea: a national survey of radiation oncologists Kim H11, Kim JY2, Kim J3, Park W4, Kim YS5, Kim HJ6, Kim YB7.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):955-61. doi: 10.4143/crt.2015.191. Epub 2016 Jan 19. Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer Kim H11, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):1074-83. doi: 10.4143/crt.2015.356. Epub 2015 Oct 29. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma Yoon MS11, Huh SJ2, Kim HJ3, Kim YS4, Kim YB5, Kim JY6, Lee JH7, Kim HJ8, Cha J9, Kim JH10, Kim J11, Yoon WS12, Choi JH13, Chun M14, Choi Y15, Lee KK16, Kim M17, Jeong JU1, Chang SK18, Park W2.
    View PubMed
  • Medicine (Baltimore). 2016 Jun;95(25):e3895. doi: 10.1097/MD.0000000000003895. Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session Oh D11, Huh SJ, Park W, Ju SG, Nam H, Lee JE.
    View PubMed
  • J Breast Cancer. 2016 Jun;19(2):169-75. doi: 10.4048/jbc.2016.19.2.169. Epub 2016 Jun 24. Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes Kim SW11, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.
    View PubMed
  • Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11. Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • J Gynecol Oncol. 2016 Mar;27(2):e17. doi: 10.3802/jgo.2016.27.e17. Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12-09) Chang JH11, Jang WI2, Kim YB3, Kim JH4, Kim YS5, Kim YS1, Park W6, Kim J7, Yoon WS8, Kim JY9, Kim HJ10.
    View PubMed
  • Cancer Res Treat. 2016 Jan;48(1):297-303. doi: 10.4143/crt.2014.333. Epub 2015 Mar 13. Can Anorectal Manometry Findings Predict Subsequent Late Gastrointestinal Radiation Toxicity in Prostate Cancer Patients Choi Y11, Park W2, Rhee PL3.
    View PubMed
  • Tumori. 2016 Jan-Feb;102(1):114-21. doi: 10.5301/tj.5000439. Epub 2015 Oct 7. Clinical significance of mucinous rectal adenocarcinoma following preoperative chemoradiotherapy and curative surgery Kim TG11, Park W2, Choi DH2, Park HC2, Kim SH3, Cho YB4, Yun SH4, Kim HC4, Lee WY4, Lee J5, Park JO5, Park YS5, Lim HY5, Kang WK5, Chun HK6.
    View PubMed
  • Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • Breast. 2015 Oct;24(5):637-41. doi: 10.1016/j.breast.2015.07.016. Epub 2015 Aug 14. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy Noh JM11, Kim KH2, Park W3, Suh CO4, Huh SJ1, Choi DH1, Keum KC2, Kim YB2.
    View PubMed
  • Technol Cancer Res Treat. 2015 Oct;14(5):525-9. doi: 10.7785/tcrt.2012.500415. Epub 2014 Nov 24. Incidental Findings on Simulation CT Images for Adjuvant Radiotherapy in Breast Cancer Patients Park JS11, Choi DH2, Huh SJ1, Park W1, Nam SJ3, Lee JE3, Kil WH3, Lee KS4.
    View PubMed
  • Clin Breast Cancer. 2015 Oct;15(5):353-61.e1-2. doi: 10.1016/j.clbc.2015.01.008. Epub 2015 Feb 7. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06) Yu JI11, Choi DH2, Huh SJ1, Cho EY3, Kim K4, Chie EK4, Ha SW4, Park IA5, Ahn SJ6, Lee JS7, Shin KH8, Kwon Y8, Kim YB9, Suh CO9, Koo JS10, Kim JH11, Jeong BG12, Kim IA13, Lee JH14, Park W1.
    View PubMed
  • Fam Cancer. 2015 Sep;14(3):365-71. doi: 10.1007/s10689-015-9789-9. Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation Kim H11, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.
    View PubMed
  • J Breast Cancer. 2015 Sep;18(3):285-90. doi: 10.4048/jbc.2015.18.3.285. Epub 2015 Sep 24. Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast Park JS11, Choi DH1, Huh SJ1, Park W1, Kim YI2, Nam SJ3, Lee JE3, Kil WH3.
    View PubMed
  • Gynecol Oncol. 2015 Sep;138(3):519-25. doi: 10.1016/j.ygyno.2015.06.030. Epub 2015 Jun 24. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17) Yoon MS11, Park W2, Huh SJ3, Kim HJ4, Kim YS5, Kim YB6, Kim JY7, Lee JH8, Kim HJ9, Cha J10, Kim JH11, Kim J12, Yoon WS13, Choi JH14, Chun M15, Choi Y16, Chang SK17, Lee KK18, Kim M19.
    View PubMed
  • Breast Cancer Res Treat. 2015 Aug;152(3):589-99. doi: 10.1007/s10549-015-3505-1. Epub 2015 Jul 23. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy Kim KH11, Noh JM, Kim YB, Chang JS, Keum KC, Huh SJ, Choi DH, Park W, Suh CO.
    View PubMed
  • Int J Gynecol Cancer. 2015 May;25(4):688-93. doi: 10.1097/IGC.0000000000000404. Correlation Between Location of Transposed Ovary and Function in Cervical Cancer Patients Who Underwent Radical Hysterectomy Yoon A11, Lee YY, Park W, Huh SJ, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Clin Breast Cancer. 2015 Apr;15(2):e105-15. doi: 10.1016/j.clbc.2014.10.002. Epub 2014 Oct 12. Unique Characteristics and Failure Patterns of Metaplastic Breast Cancer in Contrast to Invasive Ductal Carcinoma: A Retrospective Multicenter Case-Control Study (KROG 13-07) Yu JI11, Choi DH2, Huh SJ1, Ahn SJ3, Lee JS4, Shin KH5, Kwon Y5, Kim YB6, Suh CO6, Kim JH7, Cho J8, Kim IA9, Lee JH10, Park W1.
    View PubMed
  • Ann Surg Oncol. 2015 Apr;22(4):1308-14. doi: 10.1245/s10434-014-4146-z. Epub 2014 Oct 16. Salvage Radiation Therapy for Isolated Local Recurrence of Extrahepatic Cholangiocarcinoma After Radical Surgery: A Retrospective Study Kim SW11, Lim do H, Park HC, Park W, Park JO, Park YS.
    View PubMed
  • J Breast Cancer. 2015 Mar;18(1):50-6. doi: 10.4048/jbc.2015.18.1.50. Epub 2015 Mar 27. Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer Yu JI11, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):419-26. doi: 10.1016/j.ijrobp.2014.10.022. Dummy Run of Quality Assurance Program in a Phase 3 Randomized Trial Investigating the Role of Internal Mammary Lymph Node Irradiation in Breast Cancer Patients: Korean Radiation Oncology Group 08-06 Study Chung Y11, Kim JW2, Shin KH3, Kim SS4, Ahn SJ5, Park W6, Lee HS7, Kim DW8, Lee KC9, Suh HS10, Kim JH11, Shin HS12, Kim YB13, Suh CO1.
    View PubMed
  • Int J Urol. 2015 Jan;22(1):82-7. doi: 10.1111/iju.12604. Epub 2014 Sep 10. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery Chang JH11, Park W, Park JS, Pyo H, Huh SJ, Choi HY, Lee HM, Jeon SS, Seo SI.
    View PubMed
  • J Gynecol Oncol. 2015 Jan;26(1):68-74. doi: 10.3802/jgo.2015.26.1.68. Asian Society of Gynecologic Oncology International Workshop 2014 Park JY11, Ngan HY2, Park W3, Cao Z4, Wu X5, Ju W6, Chung HH7, Chang SJ8, Park SY9, Ryu SY10, Kim JH11, Cho CH12, Lee KH13, Lee JW14, Kumarasamy S15, Kim JW7, Wilailak S16, Kim BG14, Kim DY1, Konishi I17, Lee JK18, Wang KL19, Nam JH20.
    View PubMed
  • Breast. 2014 Oct;23(5):586-90. doi: 10.1016/j.breast.2014.05.025. Epub 2014 Jun 23. Excision alone for small size ductal carcinoma in situ of the breast Kim H11, Noh JM2, Choi DH3, Lee J4, Nam SJ5, Lee JE5, Park W4, Huh SJ4.
    View PubMed
  • Colorectal Dis. 2014 Aug;16(8):O257-63. doi: 10.1111/codi.12554. The adequacy of the distal resection margin after preoperative chemoradiotherapy for rectal cancer 1,chemoradiotherapy for rectal cancer.
    View PubMed
  • Eur Radiol. 2014 Jul;24(7):1514-20. doi: 10.1007/s00330-014-3167-0. Epub 2014 Apr 25. Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience Kim CK11, Park SY, Park BK, Park W, Huh SJ.
    View PubMed
  • Breast Cancer Res Treat. 2014 Jul;146(2):341-5. doi: 10.1007/s10549-014-3025-4. Epub 2014 Jun 18. Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04) Kim JH11, Choi DH, Park W, Ahn SD, Kim SS, Ha SW, Kim K, Kim YB, Yea JW, Kang MK, Shin KH, Kim DW, Lee JH, Suh CO.
    View PubMed
  • Cancer Res Treat. 2014 Jul;46(3):243-9. doi: 10.4143/crt.2014.46.3.243. Epub 2014 Jul 15. Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically 12 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06) Noh JM11, Park W, Kim JS, Koom WS, Kim JH, Choi DH, Park HC.
    View PubMed
  • Radiother Oncol. 2014 Jun;111(3):437-41. doi: 10.1016/j.radonc.2014.03.025. Epub 2014 Jun 5. A nomogram predicting the risks of distant metastasis following postoperative radiotherapy for uterine cervical carcinoma: A Korean radiation oncology group study (KROG 12-08) Je HU11, Han S1, Kim YS2, Nam JH1, Kim HJ3, Kim JW3, Park W4, Bae DS4, Kim JH5, Shin SJ5, Kim J6, Lee KH6, Yoon MS7, Kim SM7, Kim JY8, Yoon WS9, Lee NW9, Choi JH10, Park SY11, Kim JY11.
    View PubMed
  • J Radiat Res. 2014 May;55(3):553-8. doi: 10.1093/jrr/rrt141. Epub 2014 Jan 1. Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection Noh JM11, Choi DH, Park H, Huh SJ, Park W, Seol SW, Jeong BK, Nam SJ, Lee JE, Kil WH.
    View PubMed
  • Cancer?Res Treat.?2014 Apr;46(2):158-64. doi: 10.4143/crt.2014.46.2.158. Epub 2014 Apr 22. Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Lee NK11,?Kim DY2,?Kim SY3,?Oh JH3,?Park W4,?Choi DH4,?Nam TK5,?Lee KJ6.
    View PubMed
  • Cancer Genet. 2014 Apr;207(4):160-3. doi: 10.1016/j.cancergen.2014.04.002. Epub 2014 Apr 12. Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population Noh JM11, Choi DH2, Baek H3, Kim MJ4, Park H1, Huh SJ1, Park W1, Nam SJ5, Lee JE5, Kil WH5, Haffty BG6.
    View PubMed
  • Cancer Res Treat. 2014 Apr;46(2):148-57. doi: 10.4143/crt.2014.46.2.148. Epub 2014 Apr 22. Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy Kim H11, Chie EK2, Ahn YC3, Kim K2, Park W3, Yoon WS4, Huh SJ3, Ha SW2.
    View PubMed
  • Gynecol Oncol. 2014 Mar;132(3):618-23. doi: 10.1016/j.ygyno.2014.01.043. Epub 2014 Jan 31. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: A multicenter retrospective study (KROG 13-10) Noh JM11, Park W2, Kim YS3, Kim JY4, Kim HJ5, Kim J6, Kim JH7, Yoon MS8, Choi JH9, Yoon WS10, Kim JY11, Huh SJ1.
    View PubMed
  • Br J Cancer. 2014 Mar 18;110(6):1420-6. doi: 10.1038/bjc.2014.26. Epub 2014 Jan 30. Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II-III breast cancer A multicentre retrospective study (KROG 12-05) Noh JM11, Park W1, Suh CO2, Keum KC2, Kim YB2, Shin KH3, Kim K4, Chie EK4, Ha SW4, Kim SS5, Ahn SD5, Shin HS6, Kim JH7, Lee HS8, Lee NK9, Huh SJ1, Choi DH1.
    View PubMed
  • Radiother Oncol. 2014 Feb;110(2):240-4. doi: 10.1016/j.radonc.2014.01.001. Epub 2014 Jan 28. Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy Park JS11, Park W2, Pyo HR1, Park BK3, Park SY3, Choi HY4, Lee HM4, Jeon SS4, Seo SI4, Jeong BC4, Jeon HG4.
    View PubMed
  • Int J Colorectal Dis. 2014 Feb;29(2):193-200. doi: 10.1007/s00384-013-1797-3. Epub 2013 Dec 10. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients Kim TG11, Park W, Choi DH, Park HC, Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Chun HK.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):65-72. doi: 10.1016/j.ijrobp.2013.09.021. Epub 2013 Oct 22. The Role of Postmastectomy Radiation Therapy After Neoadjuvant Chemotherapy in Clinical Stage II-III Breast Cancer Patients With pN0: A Multicenter, Retrospective Study (KR0G 12-05) Shim SJ11, Park W2, Huh SJ3, Choi DH3, Shin KH4, Lee NK5, Suh CO6, Keum KC6, Kim YB6, Ahn SD7, Kim SS7, Ha SW8, Chie EK8, Kim K8, Shin HS9, Kim JH10, Lee HS11.
    View PubMed
  • Int J Radiat Biol. 2014 Jan;90(1):90-4. doi: 10.3109/09553002.2013.835504. Epub 2013 Sep 19. Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations Park H11, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, Lee JE.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):659-64. doi: 10.1016/j.ijrobp.2013.07.020. Individualized Prediction of Overall Survival After Postoperative Radiation Therapy in Patients With Early-Stage Cervical Cancer: A Korean Radiation Oncology Group Study (KROG 13-03) Lee HJ11, Han S, Kim YS, Nam JH, Kim HJ, Kim JW, Park W, Kim BG, Kim JH, Cha SD, Kim J, Lee KH, Yoon MS, Kim SM, Kim JY, Yoon WS, Lee NW, Choi JH, Park SY, Kim JY.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):867-72. doi: 10.1016/j.ijrobp.2013.02.037. Epub 2013 Jun 6. Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 12-Year Follow-up Chang JS11, Park W, Kim YB, Lee IJ, Keum KC, Lee CG, Choi DH, Suh CO, Huh SJ.
    View PubMed
  • Oncology. 2013;85(1):14-20. doi: 10.1159/000352002. Epub 2013 Jun 21. Prophylactic Supraclavicular Radiotherapy after Surgery in High-Risk N1 Breast Cancer Yu JI11, Park W, Shin KH, Lee NK, Choi DH, Huh SJ.
    View PubMed
  • J Breast Cancer. 2012 Sep;15(3):329-36. doi: 10.4048/jbc.2012.15.3.329. Epub 2012 Sep 28. Radiation Treatment in Pathologic N0-N1 Patients Treated with Neoadjuvant Chemotherapy Followed by Surgery for Locally Advanced Breast Cancer Bae SH11, Park W, Huh SJ, Choi DH, Nam SJ, Im YH, Ahn JS.
    View PubMed
  • J Breast Cancer. 2012 Mar;15(1):105-10. doi: 10.4048/jbc.2012.15.1.105. Epub 2012 Mar 28. Dose-Volume Analysis of Lung and Heart according to Respiration in Breast Cancer Patients Treated with Breast Conserving Surgery Shim JG11, Kim JK, Park W, Seo JM, Hong CS, Song KW, Lim CH, Jung HR, Kim CH.
    View PubMed
  • Indian J Exp Biol. 2012 Mar;50(3):195-200. Protective effect of triphala on radiation induced acute intestinal mucosal damage in Sprague Dawley rats Yoon WS11, Kim CY, Yang DS, Park YJ, Park W, Ahn YC, Kim SH, Kwon GY.
    View PubMed
  • Radiat Oncol. 2011 May 21;6:52. doi: 10.1186/1748-717X-6-52. Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer Bae SH11, Park W, Choi DH, Nam H, Kang WK, Park YS, Park JO, Chun HK, Lee WY, Yun SH, Kim HC.
    View PubMed
  • Onkologie. 2011;34(1-2):36-41. doi: 10.1159/000323382. Epub 2011 Jan 24. Which Patients Benefit from Preoperative Chemoradiotherapy for Intermediate Staged Rectal Cancer Yoon WS11, Park W, Choi DH, Ahn YC, Chun HK, Lee WY, Yun SH, Kim HC, Cho YB, Kang WK, Park YS, Park JO, Lim HY, Park SH, Lee J.
    View PubMed
  • Ann Surg.?2010 Dec;252(6):998-1004. doi: 10.1097/SLA.0b013e3181f3f1b1. Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01) Yeo SG11,?Kim DY,?Kim TH,?Chang HJ,?Oh JH,?Park W,?Choi DH,?Nam H,?Kim JS,?Cho MJ,?Kim JH,?Park JH,?Kang MK,?Koom WS,?Kim JS,?Nam TK,?Chie EK,?Kim JS,?Lee KJ.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1135-41. doi: 10.1016/j.ijrobp.2009.09.037. Epub 2010 Mar 16. DETERMINING WHICH PATIENTS REQUIRE IRRADIATION OF THE SUPRACLAVICULAR NODAL AREA AFTER SURGERY FOR N1 BREAST CANCER Yu JI11, Park W, Huh SJ, Choi DH, Lim YH, Ahn JS, Yang JH, Nam SJ.
    View PubMed
  • Tumori. 2010 Jul-Aug;96(4):568-76. Importance of the circumferential extent of tumors and clinical lymph node status as prognostic factors after preoperative chemoradiotherapy and surgery in patients with rectal cancer Yoon WS11, Park W, Choi DH, Ahn YC, Chun HK, Lee WY, Yun SH, Kang WK, Lim HY, Park YS.
    View PubMed
  • Radiother Oncol. 2010 Jun;95(3):359-64. doi: 10.1016/j.radonc.2010.01.007. Epub 2010 Feb 12. Prognostic significance of CD24 protein expression in patients treated with adjuvant radiotherapy after radical hysterectomy for cervical squamous cell carcinoma Sung CO11, Park W, Choi YL, Ahn G, Song SY, Huh SJ, Bae DS, Kim BG, Lee JH.
    View PubMed
  • J Korean Med Sci. 2009 Dec;24(6):1170-6. doi: 10.3346/jkms.2009.24.6.1170. Epub 2009 Nov 9. The Effect of Cyclooxygenase-2 Expression on Tumor Volume Response in Patients Treated with Radiotherapy for Uterine Cervical Cancer Kang MK11, Park W, Choi YL, Cho EY, Ahn G, Nam H, Huh SJ, Ahn YC, Lim do H, Oh DR, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2009 Dec;20(4):215-20. doi: 10.3802/jgo.2009.20.4.215. Epub 2009 Dec 28. Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma Noh JM11, Park W, Huh SJ, Cho EY, Choi YL, Lee JH, Bae DS.
    View PubMed
  • Int J Dermatol. 2009 Jul;48(7):784-6. doi: 10.1111/j.1365-4632.2009.04029.x. Scleredema adultorum of Buschke associated with a carcinoid tumor Yu JI1, Park W, Lee KK, Park W.
    View PubMed
  • J Exp Clin Cancer Res. 2008 Nov 11;27:66. doi: 10.1186/1756-9966-27-66. Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2 Park W11, Oh YT, Han JH, Pyo H.
    View PubMed
  • Ann Nucl Med. 2008 Oct;22(8):685-91. doi: 10.1007/s12149-008-0158-8. Epub 2008 Nov 4. The implication of hot spots on bone scans within the irradiated field of breast cancer patients treated with mastectomy followed by radiotherapy Park W11, Huh SJ, Yang JH, Nam SJ, Kim JH, Choi JY, Woo SY, Kim HY, Noh JM, Ryu JI.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1150-6. Epub 2007 Aug 9. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy Kwon GY11, Ha H, Ahn G, Park SY, Huh SJ, Park W.
    View PubMed
  • Yonsei Med J. 2007 Oct 31;48(5):827-32. Anal canal carcinoma: Experience from a single Korean institution Lee WS11, Chun HK, Lee WY, Yun SH, Yun H, Cho YB, Kang WK, Park YS, Huh SJ, Ahn YC, Park W.
    View PubMed
  • Gynecol Oncol. 2005 Dec;99(3):645-51. Epub 2005 Sep 8. Variation of small bowel sparing with small bowel displacement system according to the physiological status of the bladder during radiotherapy for cervical cancer Park W11, Huh SJ, Lee JE, Han Y, Shin E, Ahn YC, Lim DH.
    View PubMed
  • Cancer.?2005 Jun 1;103(11):2419-26. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma Kim DY11,?Park W,?Lim DH,?Lee JH,?Yoo BC,?Paik SW,?Kho KC,?Kim TH,?Ahn YC,?Huh SJ.
    View PubMed
  • Jpn J Clin Oncol. 2005 May;35(5):260-4. Epub 2005 May 10. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer Park W11, Park YJ, Huh SJ, Kim BG, Bae DS, Lee J, Kim BH, Choi JY, Ahn YC, Lim DH.
    View PubMed
  • Int J Radiat Oncol Biol Phys.?2005 Mar 15;61(4):1143-50. Local radiotherapy for patients with unresectable hepatocellular carcinoma Park W11,?Lim DH,?Paik SW,?Koh KC,?Choi MS,?Park CK,?Yoo BC,?Lee JE,?Kang MK,?Park YJ,?Nam HR,?Ahn YC,?Huh SJ.
    View PubMed
  • Radiother Oncol. 2004 Apr;71(1):73-9. Interfractional variation in position of the uterus during radical radiotherapy for cervical cancer Huh SJ11, Park W, Han Y.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1480-6. Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma Park W11, Chang SK, Yang WI, Ko YH, Huh SJ, Ahn YC, Suh CO.
    View PubMed

해당하는 결과가 없습니다.